HEALTHCARE GLOBAL ENTER. share price has zoomed 6% and is presently trading at Rs 436.7.
Meanwhile, the BSE HEALTHCARE index is at 43,839.0 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are KIMS (up 3.4%) and Pfizer (up 3.3%).
AJANTA PHARMA (down 1.7%) and J.B.Chemicals (down 1.5%) are among the top losers today.
Over the last one year, HEALTHCARE GLOBAL ENTER. has moved up from Rs 358.9 to Rs 436.7, registering a gain of Rs 77.8 (up 21.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,839.0, registering a gain of 54.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 156.4%), SUVEN PHARMACEUTICALS (up 106.5%) and Glenmark Pharma (up 99.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 82,382.1 (down 0.1%).
The top losers among the BSE Sensex today are Bajaj Finance (down 1.6%) and NTPC (down 1.1%). The most traded stocks in the BSE Sensex are Axis Bank and Tata Steel.
In the meantime, NSE Nifty is at 25,213.7 (down 0.1%). BPCL and IOC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 82,382.1, registering a gain of 16,870.0 points (up 25.8%).
HEALTHCARE GLOBAL ENTER. net profit grew 313.3% YoY to Rs 136 million for the quarter ended June 2024, compared to a profit of Rs 33 million a year ago. Net sales rose 14.1% to Rs 5,256 million during the period as against Rs 4,607 million in April-June 2023.
For the year ended March 2024, HEALTHCARE GLOBAL ENTER. reported 134.5% increase in net profit to Rs 413 million compared to net profit of Rs 176 million during FY23. Revenue of the company grew 12.8% to Rs 19,079 million during FY24.
The current Price to earnings ratio of HEALTHCARE GLOBAL ENTER., based on rolling 12 month earnings, stands at 118.7.
Equitymaster requests your view! Post a comment on "HEALTHCARE GLOBAL ENTER. Gains 6%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!